Chronic Obstructive Pulmonary Disease Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Chronic Obstructive Pulmonary Disease stocks.

Recent Signals

Date Stock Signal Type
2021-04-16 ADMP Lower Bollinger Band Walk Weakness
2021-04-16 APLS Crossed Above 50 DMA Bullish
2021-04-16 APLS Pocket Pivot Bullish Swing Setup
2021-04-16 AZN Narrow Range Bar Range Contraction
2021-04-16 AZN Bollinger Band Squeeze Range Contraction
2021-04-16 BLPH New Downtrend Bearish
2021-04-16 BLPH Narrow Range Bar Range Contraction
2021-04-16 DVAX Pocket Pivot Bullish Swing Setup
2021-04-16 DVAX Spinning Top Other
2021-04-16 DVAX Bollinger Band Squeeze Range Contraction
2021-04-16 DVAX Upper Bollinger Band Walk Strength
2021-04-16 DVAX Stochastic Reached Overbought Strength
2021-04-16 GTLS Bollinger Band Squeeze Range Contraction
2021-04-16 GTLS Crossed Above 50 DMA Bullish
2021-04-16 HZNP Cup with Handle Other
2021-04-16 INGN New 52 Week High Strength
2021-04-16 INGN New 52 Week Closing High Bullish
2021-04-16 INGN Upper Bollinger Band Walk Strength
2021-04-16 INVA Crossed Above 50 DMA Bullish
2021-04-16 INVA 20 DMA Resistance Bearish
2021-04-16 INVA 200 DMA Support Bullish
2021-04-16 LUNG MACD Bullish Signal Line Cross Bullish
2021-04-16 OPK MACD Bullish Signal Line Cross Bullish
2021-04-16 OPK 200 DMA Resistance Bearish
2021-04-16 PULM Lower Bollinger Band Walk Weakness
2021-04-16 VRNA 20 DMA Resistance Bearish
2021-04-16 VTVT Fell Below 20 DMA Bearish
2021-04-16 VTVT Non-ADX 1,2,3,4 Bullish Bullish Swing Setup

Recent News for Chronic Obstructive Pulmonary Disease Stocks

Date Stock Title
Apr 19 INGN Inogen to Announce First Quarter 2021 Financial Results on May 4th, 2021
Apr 19 GTLS Parker-Hannifin (PH) Exhibits Solid Prospects, Risks Persist
Apr 19 AZN Grunenthal Pharma GmbH & Co. KG -- Moody's assigns first-time B1 rating to Grünenthal; outlook stable
Apr 19 AZN UPDATE 2-Spain to trial mixing COVID vaccines after restricting AstraZeneca shot
Apr 19 AZN CureVac starts review process in Switzerland for COVID-19 vaccine hopeful
Apr 19 AZN JNJ COVID-19 Vaccine Could Return This Week With Warning, Says Anthony Fauci
Apr 19 AZN Wall Street Breakfast: Rev Up The Earnings
Apr 19 AZN Emergent BioSolutions says it has agreed with FDA not to manufacture new material at Baltimore facility
Apr 19 AZN Canada to offer AstraZeneca COVID-19 vaccine to people of age 40
Apr 19 AZN 'I don't want that' - France struggles to pitch AstraZeneca vaccine
Apr 19 AZN CORRECTED-Australia looks to speed up COVID-19 vaccine rollout to over-50s
Apr 19 AZN Quiet open for European stock markets amid reopening optimism
Apr 18 AZN Fauci expects J&J vaccinations to resume later this week
Apr 18 AZN France's Macron sees no immediate need for Russia's COVID shot
Apr 17 AZN AstraZeneca's Vaccine Data Is Still Good Enough for U.S. Authorization
Apr 17 AZN Moderna cuts UK COVID vaccine deliveries as pregnant women told mRNA jabs are safe
Apr 17 AZN AstraZeneca Is One Very Safe Hyper-Growth Blue Chip
Apr 17 HZNP 3 Reasons to Buy Horizon Therapeutics Stock and 1 Not To
Apr 16 AZN UPDATE 1-J&J scientists refute idea that COVID-19 vaccine's design linked to clots
Apr 16 AZN 'You can think of it like an annual flu shot': Doctor on possible COVID-19 booster shots

Chronic obstructive pulmonary disease (COPD) is a type of obstructive lung disease characterized by long-term breathing problems and poor airflow. The main symptoms include shortness of breath and cough with sputum production. COPD is a progressive disease, meaning it typically worsens over time. Eventually everyday activities, such as walking or getting dressed, become difficult. Chronic bronchitis and emphysema are older terms used for different types of COPD. The term "chronic bronchitis" is still used to define a productive cough that is present for at least three months each year for two years.Tobacco smoking is the most common cause of COPD, with factors such as air pollution and genetics playing a smaller role. In the developing world, one of the common sources of air pollution is poorly vented heating and cooking fires. Long-term exposure to these irritants causes an inflammatory response in the lungs, resulting in narrowing of the small airways and breakdown of lung tissue. The diagnosis is based on poor airflow as measured by lung function tests. In contrast to asthma, the airflow reduction does not improve much with the use of a bronchodilator.Most cases of COPD can be prevented by reducing exposure to risk factors. This includes decreasing rates of smoking and improving indoor and outdoor air quality. While treatment can slow worsening, no cure is known. COPD treatments include smoking cessation, vaccinations, respiratory rehabilitation, and often inhaled bronchodilators and steroids. Some people may benefit from long-term oxygen therapy or lung transplantation. In those who have periods of acute worsening, increased use of medications and hospitalization may be needed.As of 2015, COPD affected about 174.5 million (2.4%) of the global population. It typically occurs in people over the age of 40. Males and females are affected equally commonly. In 2015, it resulted in 3.2 million deaths, up from 2.4 million deaths in 1990. More than 90% of these deaths occur in the developing world. The number of deaths is projected to increase further because of higher smoking rates in the developing world, and an aging population in many countries. It resulted in an estimated economic cost of $2.1 trillion in 2010.

More about Chronic Obstructive Pulmonary Disease
Browse All Tags